<?xml version="1.0" encoding="UTF-8"?>
<ref id="rmv2054-bib-0039">
 <label>25</label>
 <mixed-citation publication-type="journal" id="rmv2054-cit-0026">
  <string-name>
   <surname>Veselenak</surname>
   <given-names>RL</given-names>
  </string-name>, 
  <string-name>
   <surname>Shlapobersky</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Pyles</surname>
   <given-names>RB</given-names>
  </string-name>, 
  <string-name>
   <surname>Wei</surname>
   <given-names>Q</given-names>
  </string-name>, 
  <string-name>
   <surname>Sullivan</surname>
   <given-names>SM</given-names>
  </string-name>, 
  <string-name>
   <surname>Bourne</surname>
   <given-names>N</given-names>
  </string-name>. 
  <article-title>A Vaxfectin(®)‐adjuvanted HSV‐2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes</article-title>. 
  <source xml:lang="en">Vaccine</source>. 
  <year>2012</year>;
  <volume>30</volume>(
  <issue>49</issue>):
  <fpage>7046</fpage>‐
  <lpage>7051</lpage>.
  <pub-id pub-id-type="pmid">23041125</pub-id>
 </mixed-citation>
</ref>
